An international Phase 2 trial will test BMS-986368 as a potentially new oral therapy for managing multiple sclerosis-related ...

A person's total number of visits to multiple sclerosis clinics is not associated with a lower risk of death, a study on ...

Researchers have developed a blood test to predict MS onset by measuring EBV antibody levels, potentially allowing early diagnosis and care.

To clarify aspects of multiple sclerosis that might be confusing, columnist Ben Hofmeister tries to use humor, analogies, and metaphors.